Chanrion, Maïa

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

Kotschy, A., Szlavik, Z., Murray, J., Davidson, J., Maragno, A. L., Le Toumelin-Braizat, G., Chanrion, M., Kelly, G. L., Gong, J.-N., Moujalled, D. M., et al. (2016) · Nature

Cell death mechanisms and regulationCancer-related Molecular Pathways

Cited by 1,047

CIP2A Is Associated with Human Breast Cancer Aggressivity

Côme, C., Laine, A., Chanrion, M., Edgren, H., Mattila, E., Liu, X., Jonkers, J., Ivaska, J., Isola, J., Darbon, J.-M., et al. (2009) · Clinical Cancer Research

Cancer Mechanisms and TherapyCancer-related Molecular Pathways

Cited by 221